Page 15 - Read Online

Page 310 Davis et al. Neuroimmunol Neuroinflammation 2020;7:300-10 I http://dx.doi.org/10.20517/2347-8659.2020.19

27. Davis RL, Buck DJ, Saffarian N, Stevens CW. The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human
astroglial cells. J Neuroimmunol 2007;186:141-9.
28. Davis RL, Das S, Buck DJ, Stevens CW. Beta-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.
Neurochem Int 2013;62:478-85.
29. Davis RL, Stevens CW, Thomas Curtis J. The opioid antagonist, beta-funaltrexamine, inhibits lipopolysaccharide-induced
neuroinflammation and reduces sickness behavior in mice. Physiol Behav 2017;173:52-60.
30. Garcia-Mesa Y, Jay TR, Checkley MA, Luttge B, Dobrowolski C, et al. Immortalization of primary microglia: a new platform to study
HIV regulation in the central nervous system. J Neurovirol 2017;23:47-66.
31. Davis RL, Buck DJ, McCracken K, Cox GW, Das S. Interleukin-1β-induced inflammatory signaling in C20 human microglial cells.
Neuroimmunol Neuroinflammation 2018;5:50.
32. Davis RL, Dertien J, Syapin PJ. Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells.
Alcohol Clin Exp Res 2002;26:1404-11.
33. Sanchez AC, Davis RL, Syapin PJ. Identification of cis-regulatory regions necessary for robust Nos2 promoter activity in glial cells:
indirect role for NF-kappaB. J Neurochem 2003;86:1379-90.
34. Lozano R, Stevens L, Thompson BC, Gilmore KJ, Gorkin R, et al. 3D printing of layered brain-like structures using peptide modified
gellan gum substrates. Biomaterials 2015;67:264-73.
35. Mangus LM, Dorsey JL, Laast VA, Hauer P, Queen SE, et al. Neuroinflammation and virus replication in the spinal cord of simian
immunodeficiency virus-infected macaques. J Neuropathol Exp Neurol 2015;74:38-47.
36. Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, et al. High predictive value of immune-inflammatory biomarkers for schizophrenia
diagnosis and association with treatment resistance. World J Biol Psychia 2015;16:422-9.
37. Davis RL, Das S, Thomas Curtis J, Stevens CW. The opioid antagonist, beta-funaltrexamine, inhibits NF-kappaB signaling and
chemokine expression in human astrocytes and in mice. Eur J Pharmacol 2015;762:193-201.